European shares closed lower on Thursday, with defence and industrial stocks leading losses, after data showed U.S. inflation ...

The predicted rise in forecourt prices comes as the amount paid by drivers for petrol has fallen by 15.5p since the start of ...

European shares ended slightly lower, driven by losses in defence and industrial sectors, amid rising U.S. inflation and ...

Sanofi has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity ...

With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a ...

FOR too long, governments have failed British industry and British workers. Administrations of all colours bought into the ...

The first phase 3 trials are due to start in the first half of next year, using devices manufactured at GSK’s facility in Evreux, France. “If successful, this could lead to regulatory ...

The market for B7-H3 inhibitors is expected to grow significantly in the coming years. This is due to the rising investment from leading pharma companies such as GSK, Merck, and others, the increasing ...

The proposed offer from Clayton, Dubilier & Rice (CD&R) would mean the sale of a 50% stake in Opella, which makes ...

EUROPEAN shares closed lower on Thursday (Oct 10), with defence and industrial stocks leading losses, after data showed US inflation ticked higher, while investors waited for France to unveil its 2025 ...

Sanofi SA is in talks to sell a 50% controlling stake in its consumer health unit to Clayton Dubilier & Rice, in what is set ...

The Bank of England risks inflicting unnecessary damage to the economy by keeping interest rates too high for too long, a ...